GRM5 and fragile X syndrome: mGluR5 antagonists are in ongoing clinical trials in FXS patients, but to date no controlled clinical trials have been performed with aripiprazole (AbilifyTM) or anticholinergics approved for human use, such as trihexyphenidyl (ArtaneTM) or benztropine (CogentinTM).